|
⚲
|
| Keyboard |
| Nichols Andrew John
✚
|
|
|---|---|
| CIK # | 0001683749 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001683749] | |
| 4 | [0001683749] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catabasis Pharmaceuticals Inc | |
| Nichols Andrew John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 55,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2021-06-02 | Grant | 600,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 60,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2019-02-13 | Grant | 40,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2018-09-07 | Grant | 150,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2018-02-08 | Grant | 100,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2017-02-09 | Grant | 100,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2016-10-03 | Grant | 13,000 | $0.00 |